# OnCo record phaxiam (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/phaxiam/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "phaxiam" ;
  schema:name "Phaxiam Therapeutics (formerly ERYtech Pharma)"@en ;
  schema:alternateName "ERYtech Pharma"@en, "Erytech"@en, "Phaxiam"@en ;
  schema:description "ERYtech Pharma was a Lyon company that encapsulated the enzyme asparaginase in red blood cells (eryaspase) for leukaemia and pancreatic cancer; after its phase 3 pancreatic trial failed in 2021 it merged into Phaxiam, which now works on bacteriophage therapy."@en ;
  schema:url <https://onco.cc/companies/phaxiam/>, <https://www.phaxiam.com> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://www.phaxiam.com>, <https://clinicaltrials.gov/search?lead=ERYtech%20Pharma>, <https://en.wikipedia.org/wiki/Erytech_Pharma> ;
  onco:tag "ctgov-sponsor" ;
  schema:addressCountry "FR" ;
  onco:cancers <https://onco.cc/cancers/pancreatic/>, <https://onco.cc/cancers/all-leukemia/> ;
  onco:sections <https://onco.cc/fronts/chemotherapy/> .